IL6 and cardiovascular disorder: Bazedoxifene is the inhibitor of IL-6/gp130 protein-protein interactions and our present studies find that Bazedoxifene can influence IL-6/gp130 interface and then inhibits IL-6/STAT3 signaling pathway in tumor and cardiovascular disease (14, 15, 52).